Published in:
01-07-2018 | Images
Acral Hyperpigmentation Resulting from Hydroxyurea Therapy in Primary Myelofibrosis
Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2018
Login to get accessExcerpt
A 77-year-old Asian man with congenital lymphedema had been diagnosed with JAK2-V617F mutation positive primary myelofibrosis for 2 years. After diagnosis, he was treated with hydroxyurea 500 mg/day. The patient has developed palmoplantar hyperpigmentation after receiving 22 months of hydroxyurea therapy (Fig. 1).
Fig. 1
Appearance of the acral skin and nails hyperpigmentation
× ![]()
…